4'-methoxy-4-methyl-2-nitrobiphenyl | 943620-09-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4'-methoxy-4-methyl-2-nitrobiphenyl
• 英文别名: 4'-Methoxy-4-methyl-2-nitro-1,1'-biphenyl；1-(4-methoxyphenyl)-4-methyl-2-nitrobenzene
• CAS: 943620-09-5
• 化学式: C₁₄H₁₃NO₃
• 分子量: 243.262
• InChiKey: SHUFXTTUXGPGOO-UHFFFAOYSA-N

物化性质

• 熔点：
  100 °C
• 沸点：
  378.3±30.0 °C(Predicted)
• 密度：
  1.176±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4'-methoxy-4-methyl-2-nitrobiphenyl 在 亚磷酸三乙酯 作用下， 生成 2-methoxy-7-methylcarbazole
  参考文献：
  名称：

  Vanadium-Catalyzed Regioselective Oxidative Coupling of 2-Hydroxycarbazoles

  摘要：

  The first regioselective oxidative coupling of 2-hydroxycarbazoles is described. With a vanadium catalyst and oxygen as the terminal oxidant, dimers with an ortho-ortho' coupling pattern were obtained with high selectivity. Further oxidation led to ortho'-ortho' coupling to generate a tetramer, which provided insight that the atropisomerization barriers of the unsymmetrical biaryl bonds are much lower than expected.

  DOI：

  10.1021/ol503521b
• 作为产物：
  描述：

  4-碘苯甲醚 、 4-溴-3-硝基甲苯 在 铜 作用下， 生成 4'-methoxy-4-methyl-2-nitrobiphenyl
  参考文献：
  名称：

  Vanadium-Catalyzed Regioselective Oxidative Coupling of 2-Hydroxycarbazoles

  摘要：

  The first regioselective oxidative coupling of 2-hydroxycarbazoles is described. With a vanadium catalyst and oxygen as the terminal oxidant, dimers with an ortho-ortho' coupling pattern were obtained with high selectivity. Further oxidation led to ortho'-ortho' coupling to generate a tetramer, which provided insight that the atropisomerization barriers of the unsymmetrical biaryl bonds are much lower than expected.

  DOI：

  10.1021/ol503521b

文献信息

• Chelation-Assisted Cross-Coupling of Anilines through In Situ Activation as Diazonium Salts with Boronic Acids under Ligand-, Base-, and Salt-Free Conditions
  作者：Roxan Joncour、Nicolas Susperregui、Noël Pinaud、Karinne Miqueu、Eric Fouquet、Jean-Marc Sotiropoulos、François-Xavier Felpin

  DOI：10.1002/chem.201300858

  日期：2013.7.8

  We describe the coupling of anilines with aryl boronic acids, under ligand‐, base‐, and salt‐free conditions at room temperature. This new reaction proceeds through the formation of an aryl palladium alkoxo complex, which allows the transmetalation step with aryl boronic acids without any external base. Importantly, this sustainable procedure generates only environmentally friendly byproducts such

  我们描述了在室温下在配体，碱和无盐条件下苯胺与芳基硼酸的偶联。该新反应通过形成芳基钯烷氧基络合物来进行，该络合物使得可以在没有任何外部碱的情况下用芳基硼酸进行金属转移步骤。重要的是，这种可持续的程序仅产生环境友好的副产品，例如t BuOH，H 2 O，N 2和B（OH）3。通过实验和理论研究对反应机理进行了深入研究。
• ANTI-VIRAL COMPOUNDS
  申请人：Rockway W. Todd

  公开号：US20070232645A1

  公开（公告）日：2007-10-04

  Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

  本发明揭示了有效抑制丙型肝炎病毒（“HCV”）或其他病毒复制的化合物。本发明还涉及包含这种化合物的组合物、与其他抗病毒或治疗剂一起配方或共同管理这种化合物的组合物、用于合成这种化合物的过程和中间体，以及使用这种化合物治疗HCV或其他病毒感染的方法。
• Carbazole Compounds and Therapeutic Uses of the Compounds
  申请人：Tucker John

  公开号：US20110305661A1

  公开（公告）日：2011-12-15

  Compounds of the general structural formula (I) and (II) and use of the compounds and salts and hydrates thereof, as therapeutic agents are disclosed. Treatable diseases and conditions include cancers, inflammatory diseases and conditions, and immunodeficiency diseases.

  本发明揭示了具有一般结构式（I）和（II）的化合物及其盐和水合物的使用作为治疗剂。可治疗的疾病和病况包括癌症、炎症性疾病和病况以及免疫缺陷病。
• Anti-Viral Compounds
  申请人：Rockway Todd W.

  公开号：US20100256139A1

  公开（公告）日：2010-10-07

  Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

  本发明揭示了一些有效抑制丙型肝炎病毒（“HCV”）或其他病毒复制的化合物。本发明还涉及包含这些化合物的组合物，这些化合物与其他抗病毒或治疗剂的联合制剂或联合给药，用于合成这些化合物的过程和中间体，以及使用这些化合物治疗HCV或其他病毒感染的方法。
• US7763731B2
  申请人：——

  公开号：US7763731B2

  公开（公告）日：2010-07-27